Health News Releases

June 04, 2024 08:57

Takeda’s TAK-861 Phase 2b Late-Breaking Data Presentations at SLEEP 2024 Demonstrate Clinically Meaningful Impact of Oral Orexin Agonist in Narcolepsy Type 1 Compared to Placebo

Takeda (TSE: 4502/NYSE:TAK (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.takeda.com%2Finvestors%2Foverview%2F&esheet=54024400&newsitemid=20240531655762&lan=en-US&anchor=TSE%3A

June 02, 2024 15:30

Accutar Biotechnology Presents Phase 1 Data of AC699 Monotherapy in Patients with ER+ / HER2- Breast Cancer at ASCO 2024

Accutar Biotechnology, Inc., a biotechnology company focusing on artificial intelligence (AI)-enabled drug discovery, announced data from an ongoing Phase 1 study of AC699 monotherapy in patients with

June 02, 2024 13:35

Morinaga Milk’s New Research Breakthrough Backed the Superiority of its Human-Residential Bifidobacteria (HRB) Strains in Metabolizing Toxin Precursor in the Gut

Morinaga Milk Industry Co., Ltd. (https://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.morinagamilk.co.jp%2Fenglish%2F&esheet=54016718&newsitemid=20240530532346&lan=en-US&anchor=Morina

June 02, 2024 13:33

Takeda Receives Positive CHMP Opinion for Recombinant ADAMTS13 (rADAMTS13) in Congenital Thrombotic Thrombocytopenic Purpura (cTTP)

Takeda (TSE:4502/NYSE:TAK (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.takeda.com%2Finvestors%2Foverview%2F&esheet=54024414&newsitemid=20240531914145&lan=en-US&anchor=TSE%3A4

June 02, 2024 13:20

UAE Commits Additional $6.26b in Industrial Offtakes

Government enterprises and private companies in the UAE committed an additional $6.26 billion to local manufacturing during the Make it in the Emirates (MIITE) Forum, which concluded on Tuesday. Organ

May 31, 2024 15:05

Parse Biosciences Launches Trailmaker Data Analysis Platform to Simplify Single Cell Sequencing

Parse Biosciences (https://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.parsebiosciences.com&esheet=54020000&newsitemid=20240530324847&lan=en-US&anchor=Parse+Biosciences&index=1&md5=af

May 31, 2024 15:00

Rhea Launches with Senior Advisory Panel, Growth Acquisitions and Strategic Partnerships to Advance Fertility Journeys for the Modern Family

Rhea (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.rhea-fertility.com%2F&esheet=54023155&newsitemid=20240530629751&lan=en-US&anchor=Rhea&index=1&md5=6bdc47f71fce37fda87be39181

May 30, 2024 16:45

JJP Biologics Announces Positive Decision to Execute a First-in-Human Clinical Trial of Anti-Inflammatory mAb JJP-1212 (anti-CD89)

JJP Biologics, a private biopharmaceutical company developing innovative antibody-based therapies, announces a positive decision, issued by the European Medicines Agency, on the Clinical Trial Applica

May 30, 2024 16:05

Asymchem Welcomes Franck Mevellec as Senior Director, Business Development

Asymchem (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fasymchem.com%2F&esheet=54019791&newsitemid=20240529046363&lan=en-US&anchor=Asymchem&index=1&md5=1c205c848b9ccf2653c34e49187b

May 30, 2024 14:55

Lenovo Powers AI Avatars to Explore the Role of Technology in Mental Health

Today, Lenovo™ released the newest iteration of its Work For Humankind (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Flenovowfh.com%2F&esheet=54018442&newsitemid=20240528448000&lan

May 30, 2024 10:15

Merck Signs MoU with KAIST to Advance Scientific Collaboration

Merck, a leading science and technology company, has signed a non-binding Memorandum of Understanding (MoU) with the Korea Advanced Institute of Science and Technology (KAIST). The academia-industry c

May 30, 2024 09:30

TVM Capital Healthcare Announces the Closing of its Saudi Arabia-Focused TVM Healthcare Afiyah Fund

TVM Capital Healthcare, an international healthcare expansion and growth capital investor, today announced the closing of the TVM Healthcare Afiyah Fund LP at approximately USD 250 million, its second

May 29, 2024 11:55

Ferrer Obtains the Distribution Rights for Treprostinil Inhalation Solution Including the Potential Indications for Idiopathic Pulmonary Fibrosis (IPF) and Progressive Pulmonary Fibrosis (PPF)

The international pharmaceutical BCorp company Ferrer continues to strengthen its focus on pulmonary vascular and interstitial lung diseases by announcing the expansion of its current distribution agr

May 28, 2024 14:58

Oncocross and JW Pharmaceutical Team Up on AI-powered Drugs for Cancer and Regeneration

Oncocross, an AI biotech company specializing in drug discovery and development, announced that it has signed a joint research agreement with JW Pharmaceutical to develop new drugs based on the AI pl

May 28, 2024 14:30

Datopotamab deruxtecan showed clinically meaningful overall survival improvement vs. chemotherapy in patients with advanced nonsquamous non-small cell lung cancer in TROPION-Lung01 Phase III trial

High-level overall survival (OS) results from the TROPION-Lung01 Phase III trial, which previously met the dual primary endpoint of progression-free survival (PFS), numerically favoured datopotamab de

May 26, 2024 10:55

European Medicines Agency (EMA) Validates Henlius and Organon Filings for Prolia® and Xgeva® (denosumab) Biosimilar Candidate HLX14

Shanghai Henlius Biotech, Inc. (2696.HK) and Organon (NYSE: OGN) today announced that the European Medicines Agency (EMA) has validated the marketing authorization applications (MAAs) for HLX14, an in

May 24, 2024 14:10

Merck to Showcase Advances in the Science of Cancer With New Data Presented at ASCO 2024

Merck, a leading science and technology company, today announced new research from the company’s diverse oncology portfolio will be presented at the 2024 American Society of Clinical Oncology (ASCO) A

May 23, 2024 14:36

Galderma Launches Restylane® VOLYME™ in China - One of the World’s Fastest Growing Aesthetics Markets

Galderma (SWX:GALD) announced today the launch of its hyaluronic acid injectable filler, Restylane® VOLYME™ in China. The company is also introducing its complementary Shape Up Holistic Individualized

May 22, 2024 17:10

Medscape Education and KDIGO Nephrology Collaboration Accelerates Improvements to Patient Care

Ahead of the 61st European Renal Association (ERA) Congress, Medscape Education and KDIGO (Kidney Disease: Improving Global Outcomes) announce an educational collaboration through a series of webinars

May 22, 2024 14:30

AstraZeneca sets ambition to deliver $80 billion Total Revenue by 2030 and sustained growth post 2030

Today AstraZeneca revealed its bold ambition to deliver $80 billion in Total Revenue by 2030, up from $45.8 billion in 2023. This will be achieved through significant growth in its existing oncology,

May 22, 2024 13:40

QPS Expands Clinic in Miami, Florida to Accommodate Increasing Demand for Obesity Trials

QPS, a leading global contract research organization (CRO), continues to expand and align its full-service preclinical, bioanalysis, and clinical capabilities with the evolution of demand for clinical

May 22, 2024 11:35

Leading Pharmaceutical Company Selects Kinaxis to Cure Supply Chain Headaches

Kinaxis (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.kinaxis.com%2Fen&esheet=54001339&newsitemid=20240521977758&lan=en-US&anchor=Kinaxis&index=1&md5=5f9eae6c7e7cdf798bb35930e

May 22, 2024 11:00

Carestream Introduces Image Suite MR 10 Software to Enhance Imaging Experience for CR and DR Imaging Systems

Carestream launches its Image Suite MR 10 Software to help deliver a boost to productivity and efficiency while enabling a more user-friendly imaging experience for radiographers. Carestream’s Imag

May 16, 2024 16:44

New Award Programme From Oral-B and the International Association for Disability and Oral Health (iADH) Champions Disability Positive Dental Practices Across Europe

Today, on Global Accessibility Awareness Day (GAAD), Oral-B proudly launches the Disability Champions Award Programme as part of its ongoing mission to make oral care more accessible to everybody. In

May 16, 2024 16:00

FinalSpark Launches the First Remote Research Platform Using Human Neurons for Biocomputing

FinalSpark, a pioneering Swiss biocomputing startup, has launched the first-ever online platform enabling global researchers to conduct experiments remotely on biological neurons in vitro. The platfor

News by Region

News by Industry